The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong
- Conditions
- Smoking Cessation
- Registration Number
- NCT04360863
- Lead Sponsor
- The University of Hong Kong
- Brief Summary
The aims of the present study are:
1. To explore the impact of COVID-19 pandemic on the smoking behavior of youth smokers
2. To explore the impact of COVID-19 pandemic on the Youth Quitline service in Hong Kong
- Detailed Description
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the globe. According to World Health Organization (WHO), due to the harmful effects on the lungs and the possible viral transmission from fingers to mouth during smoking, tobacco use is considered a major risk factor for developing COVID-19. Both tobacco use and COVID-19 can cause damage to the cardiovascular and respiratory systems. Smokers infected with COVID-19 are at higher risk of developing severe COVID-19 symptoms or death than non-smokers.
The Hong Kong SAR (HKSAR) government has announced different regulations to combat the spread of COVID-19 since late January 2020, which significantly affect the working patterns and everyday lives of people. It remains unknown how smoking habits and smoking cessation services are being affected during the pandemic.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
- Hong Kong resident aged 25 or below
- Able to communicate in Chinese (Cantonese)
- Smoked in the past 30 days
- Have difficulty to communicate via telephone
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knowledge Baseline Knowledge regarding the relationship between COVID-19 and smoking
Smoking behaviors Baseline Change in smoking behaviors of youth smokers during the pandemic
Readiness to quit Baseline Change in motivation to quit during the pandemic
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
The University of Hong Kong
🇭🇰Hong Kong, Hong Kong
The University of Hong Kong🇭🇰Hong Kong, Hong KongHo Cheung William Li, PhDContact39176634william3@hku.hk